Delivery Order SPE2DR25D1002-SPE2DR26FGN4D
Award Date 1/28/26
Potential Completion Date 1/29/26
Potential Value $9.8K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $33,932.68 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on January 7, 2026, with completion scheduled for January 8, 2026. This non-competitive delivery order utilizes firm fixed pricing and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., one of the nation's leading pharmaceutical distributors...
- The Defense Logistics Agency awarded a delivery order valued at $6,840.95 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on November 24, 2025, with completion targeted for November 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its Corporate Office location in...
- The Defense Logistics Agency awarded a delivery order valued at $11,862.59 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 13, 2026, with completion scheduled for January 14, 2026. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and identifies Conshohocken, Pennsylvania as the place of performance. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $79,223.58 to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) with a firm fixed-price structure and an ultimate completion date of January 13, 2026. This non-set-aside contract was competitively awarded and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor...
- The Defense Logistics Agency awarded a delivery order valued at $11,359.23 to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of RINVOQ ER 30 mg tablets in units of 30. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under a larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $8,835.57 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count unit doses) on August 8, 2025, with completion expected by August 11, 2025. The award represents a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a delivery order valued at $19,239.69 to AmerisourceBergen Drug Corp for RINVOQ ER 15 MG tablets (30-count units) on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a...
- The Defense Logistics Agency awarded a delivery order valued at $7,116.09 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on January 12, 2026, with an ultimate completion date of January 13, 2026. This firm fixed-price, non-set-aside contract was performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $3,611.68 to AmerisourceBergen Drug Corp for RINVOQ ER 30 mg tablets (30-count units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly...